Charles River at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

Charles River takes part in 9 sessions at ACT 2026 in San Antonio, and exhibits at Booth 303. Its program centres on modernizing toxicology studies with virtual control groups, digital pathology and new approach methods, plus nervous system risk assessment. Concrete topics include jacketed telemetry for QTc heart data and repeated MRI scans with AI analysis to monitor heart and brain toxicity in monkeys and dogs.

Organization

ACT 2026 Attendance

Charles River

Wilmington, MA

◆Diamond Supporter

criver.com

Contract research organizations (CROs)Diamond Supporter

Contract research organization running discovery and GLP safety studies worldwide, including general, genetic, reproductive and neurotoxicology, with study-data and virtual control tools.

Booth

Exhibiting at Booth 303

Mon, Nov 169:30am–6:30pmTue, Nov 178:00am–4:30pm

Talk

Sun Nov 15
8:05am–8:30am

Part of Working with Global Regulators for Streamlined Nonclinical Development (CE4)

Top Tips for Successful Nonclinical Regulatory Interaction (CE4-2)

Regulatory

Poster

Mon Nov 16
5:00pm–6:30pm

Can Jacketed Telemetry Provide QTc Data Which Is Sensetive and Reproducible to Meet ICH E14/S7B Requirements (P510)

Nelson Exhibit Ballroom · Poster P510

Safety pharmacology

Poster

Mon Nov 16
5:00pm–6:30pm

Data Driven Strategy Supporting Adequate Virtual Control Groups in Nonclinical Studies (P123)

Nelson Exhibit Ballroom · Poster P123

Study data

Poster

Mon Nov 16
5:00pm–6:30pm

Refining General Toxicology with Longitudinal MRI Assessments and AI-Enabled Analytics as a Platform for Cardioxicity and Neurotoxicity Monitoring in Cynomolgus Monkeys and Beagle Dogs (P436)

Nelson Exhibit Ballroom · Poster P436

Animal models · Safety pharmacology

Talk

Tue Nov 17
8:00am–8:55am

Virtual Control Groups and Digital Pathology: Shaping the Next Generation of Toxicologic Assessment

Grand Oaks Ballroom P

Study data · Pathology

Talk

Tue Nov 17
9:05am–9:30am

Part of What Did You Forget on Your Way to Your NDA/MAA? Strategic Considerations for Late-Stage Nonclinical Safety Studies (S09)

Immunotoxicity Studies: Integrating Immunotoxicity Assessment into Nonclinical Safety Programs (S09-2)

Immunotoxicology

Talk

Tue Nov 17
12:00pm–12:55pm

New Frontiers in NAMs Applications: Cutting-Edge Solutions for Immunogenicity, Developmental and Reproductive Toxicology, and Cardiac Safety Screening

Grand Oaks Ballroom R

New approach methods

Session

Wed Nov 18
9:00am–12:00pm

Modernizing Drug Development: Advanced Translational Methodologies for CNS and PNS Risk Assessment (S13)

Neurotoxicology · with Lilly

9:00amIntroduction on CNS Risk Assessment (S13-1)Lilly
9:10amNeurotoxicology in General Toxicology Studies: Interactive Case Studies to Explore Common Challenges, Regulatory Strategies, and Innovative Approaches (S13-2)Charles River
9:40amMechanistic Insights into Species-Specific Seizure Susceptibility (S13-3)ApconiX
10:45amThe Complexity of Drug Development Illustrated with Nav1.7-Associated Dysautonomia (S13-4)Genentech
11:10amCNS NAMs for modeling of neural plasticity and learning in neural organoids (S13-5)Johns Hopkins University

Talk

Wed Nov 18
9:10am–9:40am

Part of Modernizing Drug Development: Advanced Translational Methodologies for CNS and PNS Risk Assessment (S13)

Neurotoxicology in General Toxicology Studies: Interactive Case Studies to Explore Common Challenges, Regulatory Strategies, and Innovative Approaches (S13-2)

Neurotoxicology

Instantly find 20 buyers from Charles River

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction